Are we lowering LDL cholesterol sufficiently? (Q83855363)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16728988%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

title

Are we lowering LDL cholesterol sufficiently? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16728988%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Philip Barter

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16728988%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Kerry-Anne Rye

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16728988%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

publication date

1 June 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16728988%20AND%20SRC:MED&resulttype=core&format=json

Nature Clinical Practice Cardiovascular Medicine

28 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16728988%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16728988%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16728988%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

page(s)

290-291

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16728988%20AND%20SRC:MED&resulttype=core&format=json

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

28 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0555

7 January 2021

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0555

7 January 2021

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0555

7 January 2021

Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0555

7 January 2021

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0555

7 January 2021

Intensive lipid lowering with atorvastatin in patients with stable coronary disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0555

7 January 2021

High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0555

7 January 2021

Risk for myopathy with statin therapy in high-risk patients.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0555

7 January 2021

Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial).

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0555

7 January 2021

Identifiers

DOI

10.1038/NCPCARDIO0555

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16728988%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16728988%20AND%20SRC:MED&resulttype=core&format=json